汇宇制药发预亏，预计2025年归母净亏损2400万元至2900万元

Core Viewpoint - Huiyu Pharmaceutical (688553.SH) has announced an expected net loss for the fiscal year 2025, projecting a loss between 24 million to 29 million yuan [1] Financial Performance - The company anticipates a net profit attributable to the owners of the parent company, excluding non-recurring gains and losses, to be between 78 million to 93 million yuan for the fiscal year 2025 [1]